Format
Sort by
Items per page

Send to

Choose Destination

Best matches for parkinson's:

Parkinson's disease and the skin. Gregory R et al. Pract Neurol. (2015)

Parkinson's disease dementia: a neural networks perspective. Gratwicke J et al. Brain. (2015)

Parkinson's disease as a result of aging. Rodriguez M et al. Aging Cell. (2015)

Search results

Items: 1 to 20 of 98244

1.

Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress.

Zhong J, Yu H, Huang C, Zhong Q, Chen Y, Xie J, Zhou Z, Xu J, Wang H.

Redox Biol. 2018 Feb 14;16:47-58. doi: 10.1016/j.redox.2018.02.008. [Epub ahead of print]

PMID:
29475134
2.

Serum metabolomics study in a group of Parkinson's disease patients from northern India.

Nagesh Babu G, Gupta M, Paliwal VK, Singh S, Chatterji T, Roy R.

Clin Chim Acta. 2018 Feb 20. pii: S0009-8981(18)30083-4. doi: 10.1016/j.cca.2018.02.022. [Epub ahead of print]

PMID:
29474999
3.

Functional results and patient satisfaction after long fusion for spinal deformity in Parkinson's disease.

Scemama C, Mangone G, Bonaccorsi R, Pascal-Moussellard H.

Orthop Traumatol Surg Res. 2018 Feb 20. pii: S1877-0568(18)30046-X. doi: 10.1016/j.otsr.2017.12.019. [Epub ahead of print]

PMID:
29474946
4.

Neuroprotective Effect of Gold Nanoparticles Composites in Parkinson's Disease Model.

Hu K, Chen X, Chen W, Zhang L, Li J, Ye J, Zhang Y, Zhang L, Li CH, Yin L, Guan YQ.

Nanomedicine. 2018 Feb 20. pii: S1549-9634(18)30032-7. doi: 10.1016/j.nano.2018.01.020. [Epub ahead of print]

PMID:
29474924
5.

Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.

Aneichyk T, Hendriks WT, Yadav R, Shin D, Gao D, Vaine CA, Collins RL, Domingo A, Currall B, Stortchevoi A, Multhaupt-Buell T, Penney EB, Cruz L, Dhakal J, Brand H, Hanscom C, Antolik C, Dy M, Ragavendran A, Underwood J, Cantsilieris S, Munson KM, Eichler EE, Acuña P, Go C, Jamora RDG, Rosales RL, Church DM, Williams SR, Garcia S, Klein C, Müller U, Wilhelmsen KC, Timmers HTM, Sapir Y, Wainger BJ, Henderson D, Ito N, Weisenfeld N, Jaffe D, Sharma N, Breakefield XO, Ozelius LJ, Bragg DC, Talkowski ME.

Cell. 2018 Feb 22;172(5):897-909.e21. doi: 10.1016/j.cell.2018.02.011.

PMID:
29474918
6.

Effects of antidyskinetic nicotine treatment on dopamine release in dorsal and ventral striatum.

Leino S, Koski SK, Rannanpää S, Salminen O.

Neurosci Lett. 2018 Feb 20. pii: S0304-3940(18)30124-1. doi: 10.1016/j.neulet.2018.02.042. [Epub ahead of print]

PMID:
29474871
7.

On the importance of local dynamics in statokinesigram: A multivariate approach for postural control evaluation in elderly.

Bargiotas I, Audiffren J, Vayatis N, Vidal PP, Buffat S, Yelnik AP, Ricard D.

PLoS One. 2018 Feb 23;13(2):e0192868. doi: 10.1371/journal.pone.0192868. eCollection 2018.

PMID:
29474402
8.

Support service utilization and out-of-pocket payments for health services in a population-based sample of adults with neurological conditions.

Obembe AO, Goldsmith CH, Simpson LA, Sakakibara BM, Eng JJ.

PLoS One. 2018 Feb 23;13(2):e0192911. doi: 10.1371/journal.pone.0192911. eCollection 2018.

PMID:
29474391
9.

Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.

Achey RL, Yamamoto E, Sexton D, Hammer C, Lee BS, Butler RS, Thompson NR, Nagel SJ, Machado AG, Lobel DA.

J Neurosurg. 2018 Feb 23:1-10. doi: 10.3171/2017.8.JNS1733. [Epub ahead of print]

PMID:
29473781
10.

Stereotactic radiosurgery for tremor: systematic review.

Martínez-Moreno NE, Sahgal A, De Salles A, Hayashi M, Levivier M, Ma L, Paddick I, Régis J, Ryu S, Slotman BJ, Martínez-Álvarez R.

J Neurosurg. 2018 Feb 23:1-12. doi: 10.3171/2017.8.JNS17749. [Epub ahead of print]

PMID:
29473775
11.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27311. [Epub ahead of print]

PMID:
29473691
12.

MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.

Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O.

Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27307. [Epub ahead of print]

PMID:
29473662
13.

Facial emotion recognition in Parkinson's disease: A review and new hypotheses.

Argaud S, Vérin M, Sauleau P, Grandjean D.

Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27305. [Epub ahead of print] Review.

PMID:
29473661
14.

α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M; Barcelona LRRK2 Study Group†.

Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27295. [Epub ahead of print]

PMID:
29473656
15.

The Role of LRRK2 in Neurodegeneration of Parkinson Disease.

Rui Q, Ni H, Li D, Gao R, Chen G.

Curr Neuropharmacol. 2018 Feb 22. doi: 10.2174/1570159X16666180222165418. [Epub ahead of print]

PMID:
29473513
16.

Current limitations in the treatment Parkinson's and Alzheimer's diseases: state-of-the-art and future perspective of polymeric carriers.

Tonda-Turo C, Origlia N, Mattu C, Accorroni A, Chiono V.

Curr Med Chem. 2018 Feb 21. doi: 10.2174/0929867325666180221125759. [Epub ahead of print]

PMID:
29473493
17.

Expanding the ADCY5 phenotype toward spastic paraparesis: A mutation in the M2 domain.

Waalkens AJE, Vansenne F, van der Hout AH, Zutt R, Mourmans J, Tolosa E, de Koning TJ, Tijssen MAJ.

Neurol Genet. 2018 Jan 24;4(1):e214. doi: 10.1212/NXG.0000000000000214. eCollection 2018 Feb. No abstract available.

PMID:
29473048
18.

Leucine-Rich Repeat Kinase 2 Controls the Ca2+/Nuclear Factor of Activated T Cells/IL-2 Pathway during Aspergillus Non-Canonical Autophagy in Dendritic Cells.

Wong AYW, Oikonomou V, Paolicelli G, De Luca A, Pariano M, Fric J, Tay HS, Ricciardi-Castagnoli P, Zelante T.

Front Immunol. 2018 Feb 8;9:210. doi: 10.3389/fimmu.2018.00210. eCollection 2018.

PMID:
29472933
19.

A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway.

Antoniou N, Vlachakis D, Memou A, Leandrou E, Valkimadi PE, Melachroinou K, Re DB, Przedborski S, Dauer WT, Stefanis L, Rideout HJ.

Sci Rep. 2018 Feb 22;8(1):3455. doi: 10.1038/s41598-018-21931-8.

PMID:
29472595
20.

The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization.

Malley KR, Koroleva O, Miller I, Sanishvili R, Jenkins CM, Gross RW, Korolev S.

Nat Commun. 2018 Feb 22;9(1):765. doi: 10.1038/s41467-018-03193-0.

PMID:
29472584

Supplemental Content

Loading ...
Support Center